摘要
房间隔缺损为儿童常见的先天性心脏病,介入治疗已成为其主要的治疗方法。随着封堵器及传送装置的发展和临床经验的积累,儿童房间隔缺损介入治疗的适应证在逐渐扩大,尤其进一步放宽了年龄限制,但对小于2岁的幼儿行房间隔缺损介入治疗的安全性和效果目前尚存在争议。对于缺损较大、边缘不良、合并房间隔膨出瘤及多孔型等特殊类型房间隔缺损的介入治疗仍有很大的挑战。介入治疗房间隔缺损虽成功率高,但一些并发症尤其中远期严重并发症逐渐引起关注,长期随访至关重要,现就儿童房间隔缺损介入治疗的现状和进展作一综述。
Atrial septal defect is a common congenital heart disease in children.Percutaneous closure has evolved to become the first-line treatment strategy for most cases of atrial septal defect.With the development of devices and the growing clinical experience,indications for interventional treatment of atrial septal defect in children are gradually expanding.However,the safety and efficacy of interventional therapy for atrial septal defect in children younger than 2 years old are still controversial.Special types of atrial septal defect such as large defects, deficient surrounding rims,interatrial septal aneurysm and multi-fenestrated atrial septal defect still have great challenges.Although the techniques of percutaneous closure appear to be safe,some medium and long term complications have been brought to light,especially the long term ones.Further long time follow-up is still needed to evaluate the outcomes of this procedure.This review focuses on the status and development of ASD closure in children.
作者
刘静(综述)
韩波(审校)
Liu Jing;Han Bo(Department of Pediatric Cardiology,Shandong Provincial Hospital Affiliated to Shandong University,Jinan 250021,China)
出处
《国际儿科学杂志》
2018年第11期826-830,共5页
International Journal of Pediatrics
基金
山东省重点研发计划(2016GSF201101)
泰山学者特聘专家计划(ts201511099).
关键词
房间隔缺损
介入治疗
儿童
Atrial septal defect
Interventional therapy
Children
